Skip to content

Relay Therapeutics, Inc. RLAY Balance Sheet Statement

FY'25FY'24FY'23FY'22
$84.02M-32.4%$124.29M-13.5%$143.74M-5.3%$151.79M-45.8%
$578.28M-28.5%$809.2M+5.1%$770.1M-24.5%$1.02B+4.4%
$1.73M-70.8%$5.91M-45.8%$10.9M-6.3%$11.63M+77.8%
$470.5M-28.4%$657.04M+8.4%$606.35M-28.4%$847.12M+25.0%
$621.33M-28.7%$871.3M+3.2%$843.98M-23.3%$1.1B+9.1%
$25.58M-49.6%$50.73M+67.6%$30.27M-52.5%$63.71M+162%
$54.27M-42.0%$93.5M+1.7%$91.98M-38.5%$149.55M+35.2%
$168K0.0%$168K+32.3%$127K+5.0%$121K+11.0%
-$2.01B-15.9%-$1.74B-24.1%-$1.4B-32.3%-$1.06B-37.8%
$567.06M-27.1%$777.79M+3.4%$752M-20.9%$950.22M+5.8%
$621.33M-28.7%$871.3M+3.2%$843.98M-23.3%$1.1B+9.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Relay Therapeutics, Inc.'s total assets?
Relay Therapeutics, Inc. (RLAY) holds $699.6M in total assets, down 12.5% year over year.
How much debt does Relay Therapeutics, Inc. have?
Relay Therapeutics, Inc. carries $31.6M in total debt against $642.2M of shareholders' equity, a debt-to-equity ratio of 0.05.
How much cash does Relay Therapeutics, Inc. have?
Relay Therapeutics, Inc. holds $204.6M in cash and equivalents.
Can Relay Therapeutics, Inc. cover its short-term obligations?
Its current ratio is 22.13 — current assets exceed current liabilities.
Where does Relay Therapeutics, Inc.'s balance sheet data come from?
Every line is extracted from Relay Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.